ORMP
Oramed Pharmaceuticals Inc
4.50$
+0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 100.0% | 100.0% | 99.6% | 98.0% | 97.3% | 96.3% | 99.0% | 99.7% | 99.8% | 99.9% | 65.9% | 72.9% | 52.4% | 65.5% | 96.1% | 90.8% | 74.5% | 97.2% | 73.7% | 92.2% | 57.7% | |
| – | -3,209.1% | 100.0% | 99.0% | 41.2% | 52.6% | 82.7% | 35.0% | 83.7% | 26.2% | 8.1% | 12.2% | 9.1% | 10.3% | 10.5% | 9.6% | 43.2% | 60.3% | 25.0% | 4.1% | 35.0% | 19.9% | |
| – | -3,209.1% | 100.0% | 99.0% | 90.7% | 83.3% | 89.6% | 43.9% | 87.5% | 97.9% | 97.7% | 65.4% | 72.4% | 52.0% | 64.3% | 93.1% | 89.4% | 73.5% | 96.3% | 73.5% | 91.4% | 54.5% | |
| – | – | – | – | – | 13.4% | 4.9% | 13.1% | 1.7% | 0.7% | 1.9% | – | – | – | – | – | – | – | – | – | – | 2.0% | |
| – | – | – | – | – | – | 1.2% | 0.4% | 0.3% | 0.2% | 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 3,656.2% | 345.6% | 73.5% | 16.6% | 15.8% | 42.8% | 13.9% | 28.6% | 6.1% | 4.6% | 5.8% | 38.9% | 50.3% | 34.4% | 44.1% | 26.3% | 9.0% | 6.5% | 26.1% | 6.4% | 13.5% | |
| – | 3,656.2% | 345.6% | 73.5% | 16.6% | 11.3% | 31.6% | 10.2% | 12.2% | 5.8% | 4.5% | 5.6% | 8.5% | 13.3% | 9.6% | 15.3% | 10.2% | 5.2% | 3.6% | 24.1% | 3.7% | 8.3% | |
| – | – | – | 14.2% | – | – | – | – | – | – | – | – | – | – | – | – | 0.1% | 0.1% | 0.2% | 23.3% | 0.1% | 0.1% | |
| – | 447.1% | 30.5% | 17.6% | 16.6% | 1.4% | 3.3% | 1.1% | 0.9% | 5.1% | 4.2% | 3.6% | 3.3% | 1.5% | 2.4% | 3.9% | 1.3% | 2.0% | 1.3% | 0.2% | 0.5% | 0.2% | |
| – | -3,556.2% | -245.6% | 26.5% | 83.4% | 84.2% | 57.2% | 86.1% | 71.4% | 93.9% | 95.4% | 94.2% | 61.1% | 49.7% | 65.6% | 55.9% | 73.7% | 90.4% | 93.9% | 74.3% | 94.2% | 86.5% | |
| – | -65,740.6% | -705.4% | -231.2% | -131.6% | -306.8% | -895.0% | -336.3% | -337.9% | -255.5% | -127.6% | -133.0% | -107.4% | -145.9% | -146.0% | -234.0% | -207.5% | -89.7% | -100.9% | -71.4% | -113.7% | -53.5% | |
| – | 520,269.8% | 1,579.6% | 182.0% | 73.5% | 144.7% | 329.6% | 125.2% | 111.1% | 83.2% | 42.4% | 41.1% | 29.5% | 34.4% | 31.4% | 50.4% | 46.0% | 22.2% | 24.1% | 18.4% | 26.3% | 18.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.